Chronickidneydisease(CKD)isasignificanthealthproblemthataffectsmillionsofindividualsglobally.Theneedforeffectivetherapeuticagentshasledtotheexplorationofprobioticsasapotentialtreatment.ThisjournalfocusesonaspecificprobioticagentdesignedtoimproveCKD,itscomposition,anditsapplications,asdescribedinthep

IntroductionThispatentdelvesintothedetailedexaminationoftheAkkermansiamuciniphilaAkk007,aprobioticwithsignificantimmunomodulatoryproperties.Thestrainhasshownpromiseinenhancingimmunefunctionandisproposedforvariousapplicationsinhealthsupplementsandfunctionalfoods.Characteristics:Akkermansiamuciniphila

RecentgroundbreakingresearchpublishedinNatureMicrobiologyhashighlightedthesignificantroleofAkkermansiamuciniphila(Akk)incombatingmetabolicdisorders.Thisrevelationcomesatacrucialtimewhenmetabolicdiseasessuchastype2diabetes,non-alcoholicfattyliverdisease,andmetabolicsyndromearerisingglobally.Thesecond

Intheworldofprobiotics,Akkermansiamuciniphilaisemergingasarevolutionaryplayerwithpromisingpotentialforenhancingguthealthandaidinginweightmanagement.AtWecareProbiotics.,wearededicatedtopioneeringtheresearch,development,production,andapplicationofinnovativeprobioticstrains.Ourfocusonintestinalflora,hu

AbstractThepatentdescribesthediscoveryandapplicationofaspecificstrainofLimosilactobacillusreuteri(LR38),preservedunderCGMCCNo.24408,whichiseffectiveinimprovingpolycysticovarysyndrome(PCOS).ThestrainaddressesPCOS-relatedsymptomssuchasmetabolicleveldisordersandabnormalsexhormonelevels,providingapotent

Human-residentialprobioticsarebeneficialmicroorganismsthatnaturallyresideinthehumanbody,particularlyinthegut.Theyplayacrucialroleinmaintaininghealthandwell-being.Breastmilkisaprimarysourceofprobioticsforinfants.Itcontainsbeneficialbacteriasuchasbifidobacteriaandlactobacilli,alongwithprebioticslikehu